The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trial
No abstract is available for this record.
No abstract is available for this record.
0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.